Sintx Technologies (SINT) Competitors $2.72 -0.03 (-1.09%) Closing price 03:59 PM EasternExtended Trading$2.70 -0.02 (-0.74%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SINT vs. CLGN, ALUR, IRIX, BDMD, OSRH, PETV, RVP, NRXS, PSTV, and NXLShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include CollPlant Biotechnologies (CLGN), Allurion Technologies (ALUR), IRIDEX (IRIX), Baird Medical Investment (BDMD), OSR (OSRH), PetVivo (PETV), Retractable Technologies (RVP), NeurAxis (NRXS), Plus Therapeutics (PSTV), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. Its Competitors CollPlant Biotechnologies Allurion Technologies IRIDEX Baird Medical Investment OSR PetVivo Retractable Technologies NeurAxis Plus Therapeutics Nexalin Technology Sintx Technologies (NASDAQ:SINT) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership. Do insiders and institutionals believe in SINT or CLGN? 18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 0.0% of Sintx Technologies shares are owned by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer SINT or CLGN? In the previous week, Sintx Technologies and Sintx Technologies both had 1 articles in the media. Sintx Technologies' average media sentiment score of 0.00 equaled CollPlant Biotechnologies'average media sentiment score. Company Overall Sentiment Sintx Technologies Neutral CollPlant Biotechnologies Neutral Which has more volatility and risk, SINT or CLGN? Sintx Technologies has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Do analysts recommend SINT or CLGN? Sintx Technologies presently has a consensus price target of $28.00, indicating a potential upside of 929.41%. CollPlant Biotechnologies has a consensus price target of $11.50, indicating a potential upside of 375.21%. Given Sintx Technologies' higher probable upside, analysts plainly believe Sintx Technologies is more favorable than CollPlant Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is SINT or CLGN more profitable? Sintx Technologies has a net margin of -483.85% compared to CollPlant Biotechnologies' net margin of -560.92%. CollPlant Biotechnologies' return on equity of -87.33% beat Sintx Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sintx Technologies-483.85% -203.66% -104.76% CollPlant Biotechnologies -560.92%-87.33%-65.31% Which has higher valuation & earnings, SINT or CLGN? Sintx Technologies has higher revenue and earnings than CollPlant Biotechnologies. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSintx Technologies$2.89M2.36-$11.02M-$50.56-0.05CollPlant Biotechnologies$510K60.36-$16.61M-$1.22-1.98 SummaryCollPlant Biotechnologies beats Sintx Technologies on 10 of the 15 factors compared between the two stocks. Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.90M$6.86B$5.70B$9.48BDividend YieldN/A1.27%4.59%3.99%P/E Ratio-0.0525.4327.9019.95Price / Sales2.3650.22442.19102.72Price / CashN/A20.6736.5558.97Price / Book0.944.728.635.90Net Income-$11.02M$176.14M$3.24B$258.42M7 Day Performance-1.81%1.68%3.22%1.94%1 Month Performance-12.54%3.77%10.72%12.02%1 Year Performance-46.46%6.45%34.94%20.81% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies2.9855 of 5 stars$2.72-1.1%$28.00+929.4%-46.2%$6.90M$2.89M-0.0540CLGNCollPlant Biotechnologies1.8704 of 5 stars$2.24+10.3%$11.50+413.4%-50.3%$25.81M$510K-1.8470Gap DownHigh Trading VolumeALURAllurion Technologies2.978 of 5 stars$3.17+0.8%$22.83+621.4%-85.3%$23.42M$32.11M-0.25501IRIXIRIDEX0.481 of 5 stars$1.26flatN/A-31.5%$21.15M$48.67M-2.93120News CoverageHigh Trading VolumeBDMDBaird Medical InvestmentN/A$3.06-1.9%N/AN/A$20.54MN/A0.00N/AGap UpOSRHOSRN/A$1.08+1.9%N/AN/A$20.43MN/A0.00N/ANews CoverageGap UpPETVPetVivoN/A$0.83+3.9%N/A+33.5%$20.29M$1.05M-1.8520High Trading VolumeRVPRetractable Technologies2.0575 of 5 stars$0.66+0.5%N/A-37.6%$19.88M$33.75M-1.23240News CoverageNRXSNeurAxis2.5495 of 5 stars$2.73+4.2%$7.00+156.4%-11.5%$19.70M$2.93M-1.4819PSTVPlus Therapeutics1.6241 of 5 stars$0.38+3.4%$10.83+2,721.2%-72.0%$18.95M$5.82M-0.1320News CoverageGap UpNXLNexalin Technology2.2551 of 5 stars$1.20+10.1%$5.00+316.7%-0.8%$18.72M$170K-1.453 Related Companies and Tools Related Companies CLGN Alternatives ALUR Alternatives IRIX Alternatives BDMD Alternatives OSRH Alternatives PETV Alternatives RVP Alternatives NRXS Alternatives PSTV Alternatives NXL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SINT) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.